Boathouse Capital Supports Recapitalization of Bryn Mawr Communications
Boathouse Capital is pleased to announce that it has completed an investment in Bryn Mawr Communications, a leader in omnichannel healthcare content, education, events, and medical communications for healthcare professionals in the eyecare/vision, dermatology/aesthetics, endovascular/cardiology, and neurology specialties. The investment from Boathouse will help accelerate the company’s growth within its existing markets as well as new specialties.
Bryn Mawr Communications is a trusted partner for medical device, biopharmaceutical, and life science that rely on its clinically relevant content and leading brands to engage with key opinion leaders across multiple therapeutic specialties. Founded in 2001, Bryn Mawr Communication owns some of the most popular brands for healthcare practitioners and key opinion leaders in the US and Europe, including Cataract & Refractive Surgery Today, Modern Optometry, Practical Dermatology, Endovascular Today, Cardiac Interventions Today, and Practical Neurology. The company also operates the largest educational video-based website in the vision field and recently launched the innovative Young MD Connect platform. In addition, BMC owns and produces multiple live and virtual meetings in the healthcare space.
Andrew Olsen, Partner, remarked, “Bryn Mawr Communications has a longstanding reputation as a thought leader and resource for healthcare practitioners, particularly in the large and growing specialties of medical vision and eyecare. We see significant growth opportunities in these specialties driven by demographics, product innovation, and new channels for communicating with healthcare providers and patients. We are excited to work with David and the Bryn Mawr Communications team and draw upon our experience in healthcare marketing and communications.”
David Cox, CEO said, “This investment represents Boathouse Capital’s fourth platform investment in outsourced biopharmaceutical and life science services. I’m thrilled to have an experienced capital provider on board as we enter our next phase of growth.”